Ticker Scorecard - SNDX Basics Company: Syndax Pharmaceuticals, Inc. IPO Date: March 3, 2016 Sector: Healthcare Industry: Biotech Market Cap: $1.4B Activated in VL: True Average Daily Range Avg Daily Range: $0.40 | 2.80% Avg Daily Range (30 D): $0.27 | 1.92% Avg Daily Range (90 D): $0.31 | 2.01% Institutional Daily Volume Avg Daily Volume: .49M Avg Daily Volume (30 D): 1.76M Avg Daily Volume (90 D): 1.67M Trade Size Avg Trade Size (Sh.): 87 Avg Trade Size (Sh.) (30 D): 87 Avg Trade Size (Sh.) (90 D): 94 Institutional Trades Total Inst.Trades: 2,692 Avg Inst. Trade: $2.3M Avg Inst. Trade (30 D): $3.15M Avg Inst. Trade (90 D): $2.83M Avg Inst. Trade Volume: .13M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $2.75M Avg Closing Trade (30 D): $3.83M Avg Closing Trade (90 D): $3.55M Avg Closing Volume: 142.63K     News Feb 10, 2025 @ 10:42 PM Kuehn Law Encourages Investors of Syndax Pharmaceu... Source: N/A Jan 28, 2025 @ 6:00 PM Pulmonary Fibrosis Clinical Trial Pipeline Appears... Source: Delveinsight Sep 22, 2024 @ 4:30 AM Graft versus Host Disease Market to Increase at a ... Source: Delveinsight Apr 30, 2024 @ 3:50 PM Incyte's (INCY) Q1 Earnings & Revenues Fall Shy of... Source: Zacks Equity Research Mar 28, 2024 @ 1:54 PM Syndax (SNDX) Gets FDA Priority Tag for Leukemia D... Source: Zacks Equity Research Financials   TTM Q3 2024 Q2 2024 Basic EPS $-3.64 $-.98 $-.8 Diluted EPS $-3.64 $-.98 $-.8 Revenue $ 16M $ 12.5M $ 3.5M Gross Profit $ $ $ Net Income / Loss $ -297.06M $ -84.13M $ -68.06M Operating Income / Loss $ -321.21M $ -89.58M $ -74.22M Cost of Revenue $ $ $ Net Cash Flow $ 38.47M $ 27.62M $ -9.22M PE Ratio